Novartis Aktie
110,65
EUR
+0,15
EUR
+0,14
%
103,00
CHF
+0,12
CHF
+0,12
%
Werbung
Novartis Aktie Analyse
| 27.03.18 | Novartis Neutral | UBS AG | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.03.18 | Novartis Neutral | UBS AG | |
| 26.01.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.18 | Novartis Hold | Deutsche Bank AG | |
| 25.01.18 | Novartis Hold | S&P Capital IQ | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group | |
|
Werbung
|
|||
| 23.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.01.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | Novartis Hold | Deutsche Bank AG | |
| 10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
| 08.11.17 | Novartis Hold | Deutsche Bank AG | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 30.10.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.10.17 | Novartis Hold | S&P Capital IQ | |
| 24.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | Novartis Neutral | UBS AG | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.10.17 | Novartis Hold | Deutsche Bank AG | |
| 26.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 29.08.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.08.17 | Novartis Neutral | UBS AG | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 20.07.17 | Novartis Neutral | UBS AG | |
| 19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.17 | Novartis Hold | Deutsche Bank AG | |
| 18.07.17 | Novartis Hold | S&P Capital IQ | |
| 18.07.17 | Novartis Neutral | UBS AG | |
| 17.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.07.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 07.07.17 | Novartis Hold | Deutsche Bank AG | |
| 23.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.06.17 | Novartis Equal weight | Barclays Capital | |
| 23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Hold | Deutsche Bank AG | |
Werbung
Werbung